Research and Markets (http://www.researchandmarkets.com/research/755hql/global) has announced the addition of the "Global Radiofrequency Ablation Devices Market 2015-2019" report to their offering.
The Global Radiofrequency Ablation Devices market to grow at a CAGR of 18.24% over the period 2014-2019
Radiofrequency ablation devices are used to treat medical conditions such as cancer tumours with help of imaging techniques such as computed tomography, magnetic resonance imaging, and ultrasound by using MI techniques. This involves high frequency electromagnetic waves by generating heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, to remove or trim obstructive tissues, and deaden nerves.
One major trend upcoming in this market is the rise in the adoption of radiofrequency ablation procedures with MI techniques that have better efficacy, safety, and ease of use. Radiofrequency ablation procedures are widely used to treat many chronic tumors such as liver tumors, spinal tumors, renal cell carcinoma, and cardiac tumors. The use of imaging-guided systems has helped provide better efficacy, safety, and ease of use.
According to the report, the increase in the aging population is a major driver in the market. The elderly are more susceptible to diseases such as cardiovascular diseases, diabetes, cancer, and orthopedic and gynecologic disorders.
Further, the report states that one of the major challenges in the market is the lack of skilled electrophysiologists with expertise in the entire range of electrophysiological diagnostic and therapeutic procedures.
Radiofrequency ablation devices have been segmented based on the type of technology and type of equipment as mentioned below:
Technology
- Surgical Oncology
- Cardiology & Cardiac Rhythm Management
- Gynecology
- Hypertension
- Cosmetology
- Pain Management
Equipment
- Disposable Equipment
- Capital Equipment
- Reusable Equipment
Key Vendors
- Angiodynamics
- Boston Scientific
- Covidien
- Medtronic
- St Jude Medical
- Stryker
For more information visit http://www.researchandmarkets.com/research/755hql/global
